FDA Approves Lilly's Omvoh® (Mirikizumab-Mrkz) For Crohn's Disease, Expanding Its Use To The Second Major Type Of Inflammatory Bowel Disease
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...
Medpage Today on MSN2d
Chicken Broth Recall; Medicaid at Risk; Princess Kate Thanks Medical Staff
Princess of Wales Kate Middleton made a personal visit to thank the medical staff and speak with patients at the Royal ...
Zawya3d
FDA approves Tirzepatideas: The first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity
Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...
The Pharma Letter4h
FDA approves Lilly's Omvoh for Crohn's disease
The US Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz), from US pharma major Eli Lilly, for the ...
MedPage Today1h
Pope Injured; Dietitian Defends Ultraprocessed Foods; Woman Dies Midflight
As the Biden presidency winds down, the administration touted its Cancer Moonshot accomplishments, including regulatory action against forever chemicals and ethylene oxide, expanded access to cancer ...
pharmaphorum1d
Lilly adds another sales channel for obesity drug Zepbound
Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy ... president of Lilly Cardiometabolic Health and Lilly USA. "Our goal is to break down barriers and provide ...
usaherald21h
City of Meriden Sues Drug Makers Over Alleged Insulin Pricing Scheme
The city of Meriden, Connecticut, filed a lawsuit in federal court on Monday, accusing 20 companies, including major drug manufacturers such as CVS Health Corp., Eli Lilly and Co., and Novo Nordisk ...
Newsom committed California to making its own insulin. It’s at least a year behind his schedule
In a bid to bring down the cost of insulin, California under Gov. Gavin Newsom inked a contract to produce the drug. It's ...
PipelineReview.com3d
Lilly to acquire Scorpion Therapeutics’ mutant-selective PI3Kα inhibitor program
The acquisition will expand Lilly's oncology pipeline with STX-478, the differentiated and potentially best-in-class, mutant-selective PI3Kα inhibitor ...
How Advanced Drug Delivery is Revolutionizing Global Healthcare in 2025
USA News Group – How we deal with future spikes in disease cases and potential global pandemics is evolving rapidly. Not only is the World Economic Forum championing more ...
TMCnet3d
Amphista Therapeutics appoints Paul Medeiros as Chief Business Officer
Cambridge, UK, 13 January 2025 – Amphista Therapeutics, a leader in the discovery of next-generation, Targeted, Protein ...
Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
New York, USA, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Myocardial Infarction Clinical Trial Pipeline Appears Robust With 45+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...